Table of Contents

company-logo

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides pre­clinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.

hVIVO Dividend Announcement

• hVIVO announced a annually dividend of £0.20 per ordinary share which will be made payable on 2024-05-20. Ex dividend date: 2024-04-18
• hVIVO annual dividend for 2024 was £0.20
• hVIVO annual dividend for 2023 was £0.45
• hVIVO's trailing twelve-month (TTM) dividend yield is 0.94%
• hVIVO's payout ratio for the trailing twelve months (TTM) is 25.30%

hVIVO Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-04-18£0.20annually2024-05-20
2023-05-04£0.45annually2023-06-09

hVIVO Dividend per year

hVIVO Dividend Yield

hVIVO current trailing twelve-month (TTM) dividend yield is 0.94%. Interested in purchasing hVIVO stock? Use our calculator to estimate your expected dividend yield:

hVIVO Financial Ratios

P/E ratio8.43
PEG ratio-8.34
P/B ratio4.28
ROE54.75%
Payout ratio25.30%
Current ratio1.48
Quick ratio1.47
Cash Ratio1.05

hVIVO Dividend FAQ

Does hVIVO stock pay dividends?
hVIVO does not currently pay dividends to its shareholders.
Has hVIVO ever paid a dividend?
No, hVIVO has no a history of paying dividends to its shareholders. hVIVO is not known for its dividend payments.
Why doesn't hVIVO pay dividends?
There are several potential reasons why hVIVO would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will hVIVO ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While hVIVO has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is hVIVO a dividend aristocrat?
hVIVO is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is hVIVO a dividend king?
hVIVO is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is hVIVO a dividend stock?
No, hVIVO is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy hVIVO stocks?
To buy hVIVO you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy hVIVO stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.